Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Continuous renal replacement therapy: recent advances and future research

Nature Reviews Nephrology volume 6, pages 521–529 (2010)Cite this article

Subjects

Abstract

Continuous renal replacement therapy (CRRT) is the preferred treatment for acute kidney injury (AKI) in intensive care units (ICUs) throughout much of the developed world. Despite its widespread use, however, no formal proof exists that patient outcomes are improved when CRRT is used in preference to intermittent hemodialysis (IHD). In addition, controversy and center-specific practice variation in the clinical application of CRRT continues, owing to a lack of randomized multicenter studies of both CRRT and IHD providing level 1 data to inform clinical practice. Now, however, the publication of results from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network (ATN) study and the Randomized Evaluation of Normal versus Augmented Level Renal Replacement Therapy (RENAL) trial have provided an unparalleled quantity of information to guide clinicians. These pivotal trials investigated different intensities of CRRT in the ICU and provided level 1 evidence that effluent flow rates >25 ml/kg per hour do not improve outcomes in patients in the ICU. In this Review, we discuss the background and results of the ATN and RENAL trials and the emerging consensus that CRRT is the most appropriate treatment for AKI in vasopressor-dependent patients in the ICU. Finally, we describe the remaining controversies regarding the use of CRRT and the questions that remain to be answered.

Key Points

  • Continuous renal replacement therapy (CRRT) is now the leading form of renal replacement therapy for acute kidney injury (AKI) in intensive care units (ICUs) worldwide

  • Practice variation in the application of CRRT remains considerable owing to the absence of clear evidence-based guidelines

  • Two large, multicenter, randomized controlled trials have now established that increasing the dose of CRRT above an effluent flow rate of 25 ml/kg per hour is not beneficial

  • CRRT is now widely accepted as the most appropriate therapy for vasopressor-dependent patients who require renal replacement therapy for AKI in the ICU

  • A number of aspects of CRRT require further research, particularly the optimal threshold and timing of CRRT

  • Factors such as local experience and cost will probably continue to determine choice of therapy in different regions

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Cameron, J. S. A History of the Treatment of Renal Failure by Dialysis (Oxford University Press, 2002).

    Google Scholar 

  2. Ronco, C. et al. Management of severe acute renal failure in critically ill patients: an international survey in 345 centres. Nephrol. Dial. Transplant. 16, 230–237 (2001).

    Article  CAS  Google Scholar 

  3. Bellomo, R. & Ronco, C. Continuous renal replacement therapy in the intensive care unit. Intensive Care Med. 25, 781–789 (1999).

    Article  CAS  Google Scholar 

  4. Forni, L. G. & Hilton, P. J. Continuous hemofiltration in the treatment of acute renal failure. N. Engl. J. Med. 336, 1303–1309 (1997).

    Article  CAS  Google Scholar 

  5. Uchino, S., Fealy, N., Baldwin, I., Morimatsu, H. & Bellomo, R. Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin. Pract. 94, c94–c98 (2003).

    Article  Google Scholar 

  6. Ronco, C. Evolution of hemodiafiltration. Contrib. Nephrol. 158, 9–19 (2007).

    Article  Google Scholar 

  7. Cerdá, J. & Ronco, C. Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin. Dial. 22, 114–122 (2009).

    Article  Google Scholar 

  8. Ricci, Z. et al. Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit. Care 10, R67 (2006).

    Article  Google Scholar 

  9. Liao, Z. et al. Kinetic comparison of different acute dialysis therapies. Artif. Organs 27, 802–807 (2003).

    Article  Google Scholar 

  10. Ronco, C. & Bellomo, R. Dialysis in intensive care unit patients with acute kidney injury: continuous therapy is superior. Clin. J. Am. Soc. Nephrol. 2, 597–600 (2007).

    Article  Google Scholar 

  11. RENAL Study Investigators. Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. Crit. Care Resusc. 10, 225–230 (2008).

  12. Uchino, S. et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813–818 (2005).

    Article  CAS  Google Scholar 

  13. Pronovost, P. J. et al. Team care: beyond open and closed intensive care units. Curr. Opin. Crit. Care 12, 604–608 (2006).

    Article  Google Scholar 

  14. Bellomo, R. & Mehta, R. Acute renal replacement in the intensive care unit: now and tomorrow. New Horiz. 3, 760–767 (1995).

    CAS  PubMed  Google Scholar 

  15. Mehta, R. L. & Letteri, J. M. Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on Dialysis. Am. J. Nephrol. 19, 377–382 (1999).

    Article  CAS  Google Scholar 

  16. Mendelssohn, D. C., Mullaney, S. R., Jung, B., Blake, P. G. & Mehta, R. L. What do American nephrologists think about dialysis modality selection? Am. J. Kidney Dis. 37, 22–29 (2001).

    Article  CAS  Google Scholar 

  17. VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N. Engl. J. Med. 359, 7–20 (2008).

  18. RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-replacement therapy in critically ill patients. N. Engl. J. Med. 361, 1627–1638 (2009).

  19. Uchino, S. The epidemiology of acute renal failure in the world. Curr. Opin. Crit. Care 6, 538–543 (2006).

    Article  Google Scholar 

  20. Bagshaw, S. M. et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J. Crit. Care 24, 129–140 (2009).

    Article  Google Scholar 

  21. Uchino, S. et al. Continuous renal replacement therapy: a worldwide practice survey: The Beginning and Ending Supportive Therapy for the Kidney (B. E. S. T. Kidney) Investigators. Intensive Care Med. 33, 1563–1570 (2007).

    Article  Google Scholar 

  22. Uchino, S. et al. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int. J. Artif. Organs 30, 281–292 (2007).

    Article  CAS  Google Scholar 

  23. Bell, M. et al. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med. 33, 773–780 (2007).

    Article  Google Scholar 

  24. Mehta, R. L. et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int. 60, 1154–1163 (2001).

    Article  CAS  Google Scholar 

  25. John, S. et al. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol. Dial. Transplant. 16, 320–327 (2001).

    Article  CAS  Google Scholar 

  26. Kielstein, J. T. et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am. J. Kidney Dis. 43, 342–349 (2004).

    Article  CAS  Google Scholar 

  27. Augustine, J. J., Sandy, D., Seifert, T. H. & Paganini, E. P. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am. J. Kidney Dis. 44, 1000–1007 (2004).

    Article  Google Scholar 

  28. Uehlinger, D. E. et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol. Dial. Transplant. 20, 1630–1637 (2005).

    Article  Google Scholar 

  29. Vinsonneau, C. et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368, 379–385 (2006).

    Article  Google Scholar 

  30. Lins, R. L. et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol. Dial. Transplant. 24, 512–518 (2009).

    Article  Google Scholar 

  31. Kellum J. A. et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med. 28, 29–37 (2002).

    Article  Google Scholar 

  32. Ghahramani, N., Shadrou, S. & Hollenbeak, C. A systematic review of continuous renal replacement therapy and intermittent haemodialysis in management of patients with acute renal failure. Nephrology (Carlton) 13, 570–578 (2008).

    Article  Google Scholar 

  33. Rabindranath, K., Adams, J., Macleod, A. M. & Muirhead, N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD003773. doi:10.1002/14651858.CD003773.pub3 (2007).

    Google Scholar 

  34. Klarenbach, S. et al. Economic evaluation of continuous renal replacement therapy in acute renal failure. Int. J. Technol. Assess. Health Care 25, 331–338 (2009).

    Article  Google Scholar 

  35. Srisawat, N., Lawsin, L., Uchino, S., Bellomo, R. & Kellum, J. A. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit. Care 14, R46 (2010).

    Article  Google Scholar 

  36. Bouchard, J. & Mehta, R. L. Volume management in continuous renal replacement therapy. Semin. Dial. 22, 146–150 (2009).

    Article  Google Scholar 

  37. Bouchard, J. et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 76, 422–427 (2009).

    Article  Google Scholar 

  38. Payen, D. et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit. Care 12, R74 (2008).

    Article  Google Scholar 

  39. Brandstrup, B. et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann. Surg. 238, 641–648 (2003).

    Article  Google Scholar 

  40. Stewart, R. M. et al. Less is more: improved outcomes in surgical patients with conservative fluid administration and central venous catheter monitoring. J. Am. Coll. Surg. 208, 725–735 (2009).

    Article  Google Scholar 

  41. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354, 2564–2575 (2006).

  42. Zucchelli, P. & Santoro, A. Dialysis-induced hypotension: a fresh look at pathophysiology. Blood Purif. 11, 85–98 (1993).

    Article  CAS  Google Scholar 

  43. Conger, J. D. Does hemodialysis delay recovery from acute renal failure? Semin. Dial. 3, 146–148 (1990).

    Article  Google Scholar 

  44. Manns, M., Sigler, M. H. & Teehan, B. P. Intradialytic renal haemodynamics—potential consequences for the management of the patient with acute renal failure. Nephrol. Dial. Transplant. 12, 870–872 (1997).

    Article  CAS  Google Scholar 

  45. Jacka, M. J., Ivancinova, X. & Gibney, R. T. Continuous renal replacement therapy improves renal recovery from acute renal failure. Can. J. Anaesth. 52, 327–332 (2005).

    Article  Google Scholar 

  46. Bellomo, R. et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8, R204–R212 (2004).

    Article  Google Scholar 

  47. Liu, K. D. et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin. J. Am. Soc. Nephrol. 1, 915–919 (2006).

    Article  CAS  Google Scholar 

  48. Gettings, L. G., Reynolds, H. N. & Scalea, T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med. 25, 805–813 (1999).

    Article  CAS  Google Scholar 

  49. Shiao, C. C. et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit. Care 13, R171 (2009).

    Article  Google Scholar 

  50. Doi, K. et al. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J. Am. Soc. Nephrol. 20, 1217–1221 (2009).

    Article  CAS  Google Scholar 

  51. Demirkiliç, U. et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J. Card. Surg. 19, 17–20 (2004).

    Article  Google Scholar 

  52. Elahi, M. M., Lim, M. Y., Joseph, R. N., Dhannapuneni, R. R. & Spyt, T. J. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur. J. Cardiothorac. Surg. 26, 1027–1031 (2004).

    Article  Google Scholar 

  53. Bouman, C. S., Oudemans- Van Straaten, H. M., Tijssen, J. G., Zandstra, D. F. & Kesecioglu, J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit. Care Med. 30, 2205–2211 (2002).

    Article  Google Scholar 

  54. Clark, W. R., Mueller, B. A., Kraus, M. A. & Macias, W. L. Renal replacement therapy quantification in acute renal failure. Nephrol. Dial. Transplant. 13 (Suppl. 6), 86–90 (1998).

    Article  Google Scholar 

  55. Vesconi, S. et al. Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit. Care 13, R57 (2009).

    Article  Google Scholar 

  56. Ronco, C. et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356, 26–30 (2000).

    Article  CAS  Google Scholar 

  57. Saudan, P. et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 70, 1312–1317 (2006).

    Article  CAS  Google Scholar 

  58. Tolwani, A. J. et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J. Am. Soc. Nephrol. 19, 1233–1238 (2008).

    Article  Google Scholar 

  59. Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 7, 707–710 (1996).

    Article  Google Scholar 

  60. Palevsky, P. M. et al. Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. Crit. Care 13, 310 (2009).

    Article  Google Scholar 

  61. Gotch, F. A. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol. Dial. Transplant. 13 (Suppl. 6), 10–14 (1998).

    Article  CAS  Google Scholar 

  62. Uchino, S., Bell, M. & Bellomo, R. Renal support in critically ill patients with acute kidney injury. N. Engl. J. Med. 359, 1961; author reply 1961–1962 (2008).

    CAS  PubMed  Google Scholar 

  63. Khosla, N. et al. Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury. Clin. J. Am. Soc. Nephrol. 4, 1914–1919 (2009).

    Article  CAS  Google Scholar 

  64. Hsu, C. Y. et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin. J. Am. Soc. Nephrol. 4, 891–898 (2009).

    Article  Google Scholar 

  65. Lin, Y. F. et al. The 90-day mortality and the subsequent renal recovery in critically ill surgical patients requiring acute renal replacement therapy. Am. J. Surg. 198, 325–332 (2009).

    Article  Google Scholar 

  66. Prowle, J. R., Echeverri, J. E., Ligabo, E. V., Ronco, C. & Bellomo, R. Fluid balance and acute kidney injury. Nat. Rev. Nephrol. 6, 107–115 (2010).

    Article  Google Scholar 

  67. Reade, M. C. et al. Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med. 36, 11–21 (2009).

    Article  Google Scholar 

  68. Kellum, J. A. & Ronco, C. Dialysis: results of RENAL—what is the optimal CRRT target dose? Nat. Rev. Nephrol. 6, 191–192 (2010).

    Article  Google Scholar 

  69. Haase, M. et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 54, 1012–1024 (2009).

    Article  CAS  Google Scholar 

  70. Lameire, N., Van Biesen, W. & Vanholder, R. The changing epidemiology of acute renal failure. Nat. Clin. Pract. Nephrol. 2, 364–377 (2006).

    Article  Google Scholar 

  71. Beck, D. H., Taylor, B. L., Millar, B. & Smith, G. B. Prediction of outcome from intensive care: a prospective cohort study comparing Acute Physiology and Chronic Health Evaluation II and III prognostic systems in a United Kingdom intensive care unit. Crit. Care Med. 25, 9–15 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, Austin Health, 145 Studley Road, Heidelberg, 3084, Vic, Australia

    John R. Prowle & Rinaldo Bellomo

Authors
  1. John R. Prowle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rinaldo Bellomo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J. R. Prowle wrote the article and both authors contributed equally to researching data for the article, discussing the content, and reviewing and/or editing the manuscript before submission.

Corresponding author

Correspondence to Rinaldo Bellomo.

Ethics declarations

Competing interests

R. Bellomo was lead author and principal investigator of the Randomized Evaluation of Normal versus Augmented Level (RENAL) Replacement Therapy Study. He has received consulting fees from Gambro Biosite, Abbott Diagnostics, and Philips Medical Systems, and grant support from Fresenius Kabi, Bard, Pfizer, and Gambro. For the RENAL study, Gambro provided Hemosol dialysate® and replacement fluids at a favorable price. J. R. Prowle declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prowle, J., Bellomo, R. Continuous renal replacement therapy: recent advances and future research. Nat Rev Nephrol 6, 521–529 (2010). https://doi.org/10.1038/nrneph.2010.100

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2010.100

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing